CRP/LYMPHOCYTE RATIO IN PATIENTS WITH COVID-19 WITH HEADACHE

Abstract

Aim: One of the most common neurologic symptoms observed in COVID-19 is headache. The pathogenesis of this headache is still not clearly defined. In our study, we aimed to reveal the relationship between headache observed in patients with COVID-19 and the C-reactive protein CRP/lymphocyte ratio, an indicator of inflammation. Material and Method: The demographic, clinical, and laboratory characteristics of patients followed up with a diagnosis of COVID-19 were recorded. The clinical and laboratory findings of patients with and without headache were compared. Results: A total of 106 patients were included in the study. The mean age of all patients was 60.81 ± 15.03 years and 50.9% were male. The mean age of the patient group with headache (57.77 ± 15.42 years) was significantly lower than the mean age of the group without headache (64.22 ± 13.95 years) (p=0.027). The smoking rate was also higher in this group (p=0.003). Smell and taste disorders were also found to be significantly higher in patients with headache compared with patients without headache (p=0.003). When the groups were compared in terms of the CRP/lymphocyte ratio, no significant difference was found (p

Keywords

• covid-19
• sars-cov-2 enfeksiyonu
• baş ağrısı
• c-reactive protein
• i̇nflamasyon
• crp/lenfosit oranı
• covid-19
• sars-cov-2 infection
• headache
• c-reactive protein
• inflammation
• crp/lymphocyte ratio